Cardiovascular risk functions: Usefulness and limitations;Las funciones de riesgo cardiovascular: utilidades y limitaciones

Revista Espanola de Cardiologia

Volumn 67, Issue 2, 2014, Pages 77-79

  Elosua, Roberto ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; REVIEW; CARDIOVASCULAR DISEASES; FEMALE; HUMAN; MALE; PROCEDURES; RISK ASSESSMENT;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; RISK ASSESSMENT;

EID: 84937965292     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2013.09.014     Document Type: Article

References (19)

1. I.R. Dégano, R. Elosua, and J. Marrugat Epidemiología del síndrome coronario agudo en España: estimación del número de casos y la tendencia de 2005 a 2049 Rev Esp Cardiol 66 2013 472 481
2. G. Rose Sick individuals and sick populations Int J Epidemiol 14 1985 32 38
3. F. Agüero, I.R. Dégano, I. Subirana, M. Grau, A. Zamora, and J. Sala et al. Impact of a partial smoke-free legislation on myocardial infarction incidence, mortality and case-fatality in a population-based registry: the REGICOR Study PLoS One 8 2013 e53722
4. C. Brotons, I. Moral, N. Soriano, L. Cuixart, D. Osorio, and D. Bottaro et al. Impacto de la utilización de las diferentes tablas SCORE en el cálculo del riesgo cardiovascular Rev Esp Cardiol. 67 2014 94 100
5. R.B. D'Agostino, R.S. Vasan, M.J. Pencina, P.A. Wolf, M. Cobain, and J.M. Massaro et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
6. J.I. Cuende Edad vascular derivada del SCORE y Guía europea sobre prevención de la enfermedad cardiovascular en la práctica clínica (versión 2012) Rev Esp Cardiol 66 2013 241
7. J. Marrugat, I. Subirana, E. Comín, C. Cabezas, J. Vila, and R. Elosua et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study J Epidemiol Community Health 61 2007 40 47 Errata: J Epidemiol Community Health. 2007;61:655
8. J. Perk, G. De Backer, H. Gohlke, I. Graham, Z. Reiner, and M. Verschuren et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) Eur Heart J 33 2012 1635 1701 Errata: Eur Heart J. 2012;33:2126
9. Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581-90.
10. C. Brotons, J.M. Lobos, M.A. Royo-Bordonada, A. Maiques, A. De Santiago, and A. Castellanos et al. Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care BMC Fam Pract 14 2013 36
11. J.M. Baena-Díez, F.J. Félix, M. Grau, A. Cabrera de León, H. Sanz, and M. Leal et al. Tratamiento y control de los factores de riesgo según el riesgo coronario en la población española del estudio DARIOS Rev Esp Cardiol 64 2011 766 773 Errata: Rev Esp Cardiol. 2012;65:110
12. R.B. D'Agostino Sr, and M.J. Pencina Invited commentary: Clinical usefulness of the Framingham Cardiovascular risk profile beyond its statistical performance Am J Epidemiol 176 2012 187 189
13. J. Marrugat, J. Vila, J.M. Baena-Díez, M. Grau, J. Sala, and R. Ramos et al. Validez relativa de la estimación del riesgo cardiovascular a 10 años en una cohorte poblacional del estudio REGICOR Rev Esp Cardiol 64 2011 385 394
14. S.M. Liew, J. Doust, and P. Glasziou Cardiovascular risk scores do not account for the effect of treatment: a review Heart 97 2011 689 697
15. J. Hippisley-Cox, C. Coupland, J. Robson, and P. Brindle Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database BMJ 341 2010 c6624
16. J.T. Wilkins, H. Ning, J. Berry, L. Zhao, A.R. Dyer, and D.M. Lloyd-Jones Lifetime risk and years lived free of total cardiovascular disease JAMA 308 2012 1795 1801
17. M.A. Royo-Bordonada, J.M. Lobos, C. Brotons, F. Villar, C. De Pablo, and P. Armario et al. El estado de la prevención cardiovascular en España Med Clin (Barc) 2013 http://dx.doi.org/10.1016/j.medcli.2012.09.046
18. M.A. Royo-Bordonada, J.M. Lobos Bejarano, F. Villar Álvarez, S. Sans, A. Pérez, and J. Pedro-Botet et al. Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las guías europeas de prevención cardiovascular 2012 Rev Esp Salud Pública 87 2013 103 120
19. M.G. Allan, F. Nouri, C. Korownyk, M.R. Kolber, B. Vandermeer, and J. McCormack Agreement among cardiovascular disease risk calculators Circulation 127 2013 1948 1956